CYTOSORBENTS, INC.

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2010–2023

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	4	1
2011	—	4	1
2010	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
AMERICAN DEFENSE INTERNATIONAL INC	—	57

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	7
SENATE	6
Defense, Dept of (DOD)	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Defense	Defense	8
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	1

Bills Explicitly Cited (1)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2647110th Congress

Mental Health and Substance Abuse Juvenile Services Improvement Act of 2007

2010 · first_quarter · Firm: AMERICAN DEFENSE INTERNATIONAL INC

Open original LDA filing ↗

Cited source text and reported amounts

Department of Defense Appropriations Bill, provisions relating to blood purification research. National Defense Authorization Act (HR2647), provisions relating to blood purification research.

Client expense: — · Firm income: —

Matched citations: HR2647

Source: Senate LDA

CYTOSORBENTS, INC. — Lobbying Disclosure | Poliscope